Concourse Financial Group Securities’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 2422 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 4056 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 4050 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 4088 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 4101 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 4040 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 4004 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 3964 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 3872 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 3837 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 3619 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 3670 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 3619 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 3746 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 3697 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 3594 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 3518 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 3441 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 3282 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 3186 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 3220 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 3163 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 2876 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 3204 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 3185 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 3068 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 2652 |
|